POSTER SESSION II
Monday, March 3, 2008   —  1:00 PM - 4:30 PM
Convention Center, Exhibit Hall A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


HEMATOPATHOLOGY



Poster#Title and AuthorsItinerary
Planner
169 Microenvironmental Colocalization of CD10-Positive Dendritic Bone Marrow Stromal Cells at Diagnosis Predicts Survival after Autologous Stem Cell Transplantation in Multiple Myeloma (1182)
A Jünger, C Fibich, M Voralia, H Neufeld, H Doell, J DeCoteau, E Torlakovic - Royal University Hospital, University of Saskatchewan, Saskatoon, SK, Canada; Saskatchewan Cancer Agency, Saskatoon, SK, Canada; University of Saskatchewan, Saskatoon, SK, Canada 		Add
170 Phosphorylation of the Retinoblastoma Protein Correlates with Response but Not del(13q) in Multiple Myeloma (1158)
S Ely, R Niesvizky, M Coleman, S Mathew, DM Knowles, S Chen-Kiang - Weill Cornell Medical College, New York, NY 		Add
171 Over Expression of cyclin B2 Predicts Poor Clinical Outcome among Multiple Myeloma Patients Post Autologous Stem Cell Transplant (1206)
A Mansoor, DA Stewart, B Shin, B Roland, MTS Rad, A Magliocco, N Bahlis - University of Calgary/ Calgary Laboratory Services, Calgary, AB, Canada; University of Calgary /TBCC, Calgary, AB, Canada 		Add
172 Monoallelic Immunoglobulin Heavy Chain Gene Deletion with Illegitimate Recombination of the 2nd Allele Is the Most Common Mechanism for the Light Chain Only Phenotype in Multiple Myeloma (1146)
C Cohn, S Mathew, R Niesvizky, DM Knowles, S Chen-Kiang, S Ely - Weill Cornell Medical College, New York, NY 		Add
173 Flow Cytometric Analysis of Neoplastic Plasma Cells by Surface Light Chain Expression (1282)
EX Wei, LE Grosso - Saint Louis University, St. Louis, MO 		Add
174 Flow Cytometric Determination of Clonotypic B-Lymphocytes (Myeloma Precursor Cells) in Multiple Myeloma (1148)
E Conway, J Wen, A Mo, Y Feng, L Novoa-Takara, C Chang - The Methodist Hospital/TMHRI, Houston, TX; Medical College of Wisconsin, Madison, WI; Weill Medical Coll. of Cornell Univ., New York, NY 		Add
175 The Genomic Profile of Plasma Cell Leukemia by Interphase Fluorescence In Situ Hybridization (1233)
C Qi, J Yeung, W Xu, H Chang - University of Toronto, Toronto, Canada 		Add
176 Identification of Chromosomal Aberrations in Multiple Myeloma with Combined G-Banding and Interphase Fluorescence In Situ Hybridization Analyses (1123)
D Ang, PA Rodriguez Urrego, J Wang, K Vasallo, H Aviv - UMDNJ-RWJUH, New Brunswick, NJ 		Add
177 Monitoring Myelomatosis: Bone Marrow with Immunoperoxidase Staining Versus Serum and Urine High Resolution Electrophoresis with Immunofixation Electrophoresis (1271)
AD Tatsas, TL McCurley, MH Jagasia, H Chen - Vanderbilt University, Nashville, TN 		Add
178 Bcl-2 in Monoclonal B Cells of Reactive Follicular Hyperplasia. A Flow Cytometry Study (1241)
VG Robu, TP Singleton - University of Minnesota, Minneapolis, MN 		Add
179 Infectious Mononucleosis; Morphology and Immunophenotype in Cervical Lymph Nodes and Waldeyer's Ring (1202)
A Louissaint, Jr., C Soupir, A Ganguly, RP Hasserjian, JA Ferry, NL Harris, LR Zukerberg - Massachusetts General Hospital, Boston, MA 		Add
180 Luetic Infection in Nodal Inflammatory Pseudotumor (1180)
P Incardona, F Facchetti, M Ponzoni, P Chiodera - Spedali Civili Brescia, Brescia, Italy; S.Raffaele Hospital, Milan, Italy; S.Anna Clinic, Brescia, Italy 		Add
181 Epidemiological Data of Leukemias and Lymphomas Suggest and Support Distinct Biological Groups (1231)
D Poncini, V Stucki, S Giger, D Korol, R Maurer, C Renner, N Probst-Hensch, H Moch, E Levi, M Kurrer - University Hospital Zurich; University of Zurich and City Hospital Triemli, Zurich, Switzerland; John D. Dingell VA Medical Center and Wayne State University, Detroit, MI; Cantonal Hospital Aarau, Aarau, Switzerland 		Add
182 The Association between Malignant Lymphomas and Epstein-Barr Virus in the West of Ireland. A Pathological, Epidemiological and Virological Study (1266)
CS Tan, V Phelan, CE Connolly - University College Hospital, Galway, Ireland 		Add
183 TAp63 and DNp63 Protein Expressions in Malignant Lymphomas and Leukemias (1252)
BK Shin, X Zhang, Z Lin, I Kim - Korea University Medical College, Seoul, Republic of Korea; Yanbian University Medical College, Yanji, China 		Add
184 Expression of mTOR Pathway Proteins and Notch1 in Lymphoblastic Lymphoma (1255)
J Smock, AM Agarwal, MS Lim, SL Perkins - University of Utah Health Sciences Center, Salt Lake City, UT; University of Michigan, Ann Arbor, MI 		Add
185 CD166/HCA/ALCAM Immunoreactivity Patterns in Hematopoietic Tissues and Neoplasms (1230)
JM Polski, JA King, S Chapman, S Ofori-Acquah - University of South Alabama, Mobile, AL; Emory University, Atlanta, GA 		Add
186 Standardized PCR Assays Compare Well with Southern Blots for the Assessment of T/B-Cell Clonality in Lymphoproliferative Disorders (1285)
BM Wildemore, D Zepf, G Milman, NI Lindeman - Brigham and Women's Hospital, Harvard Medical School, Boston, MA 		Add
187 Prevalence of Elevated Hemoglobin A2 Measured by Capillary Electrophoresis (1286)
Z Yang, VVB Reddy - University of Alabama School of Medicine, Birmingham, AL 		Add
188 Clinical Significance of Acquired Activated Protein C Resistance Caused by Lupus Anticoagulants (1246)
AJ Saenz, E Van Cott - Massachusetts General Hospital, Boston, MA 		Add
189 Thymoma: Immunohistochemistry Study with Emphasis on Lymphoid Markers (CD57, CD20, CD3, and CD5) and Clinicopathologic Correlation (1189)
T Khoury, A Arshad, M Arnouk, S Alrawi, D Tan - Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo; Univ of Texas M.D. Anderson Cancer Center, Houston, TX 		Add